Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Intranasal Administration: Potential Route as Diverse Targeting Systems"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (5 November 2022) | Viewed by 28157
Special Issue Editors
Interests: nasal absorption; cervical lymph node targeting; lymphatic delivery; powdery formulation; peptide drug delivery; brain targeting
Interests: nasal formulation; nasal drug delivery; mucosal absorption; CNS drug delivery; brain drug targeting; neuroinflammation; neuropathic pain; neurodegenerative diseases; sleep cycle; chronopharmacology; circadian rhythm
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
The intranasal administration route can deliver drugs directly to the brain, central nervous system (CNS) region, and the lymphatic tissues, as well as through mucosal absorption. The drug delivery system using the intranasal administration is a useful tool for the development of new treatment strategies for various diseases (e.g., CNS diseases, tumour, and acute pain). This Special Issue will address the advances of the nasal drug delivery system, focusing the development of the drug delivery system to various target tissues (e.g., nose-to-brain, nose-to lymph, mucosal absorption, and nasal topical use). In addition, this Issue includes not only drug targeting to the brain and lymph, but also nasal formulation development such as newly dosage forms (powder, mucoadhesion, gelation, micro (nano) particulation, etc.), intranasal dissolution, and mucosal permeation.
Dr. Tomoyuki Furubayashi
Dr. Daisuke Inoue
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Intranasal administration
- Brain targeting
- Lymphatic delivery
- Mucosal absorption
- Nasal formulation development
- Intranasal dissolution and permeation